Jpmorgan Chase & CO Absci Corp Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Absci Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 122,768 shares of ABSI stock, worth $430,915. This represents 0.0% of its overall portfolio holdings.
Number of Shares
122,768
Previous 56,986
115.44%
Holding current value
$430,915
Previous $149,000
106.71%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding ABSI
# of Institutions
139Shares Held
68.6MCall Options Held
421KPut Options Held
543K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10MShares$35.3 Million0.21% of portfolio
-
Redmile Group, LLC San Francisco, CA8.25MShares$29 Million2.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.45MShares$22.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.34MShares$18.8 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY3.93MShares$13.8 Million0.05% of portfolio
About Absci Corp
- Ticker ABSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 92,843,504
- Market Cap $326M
- Description
- Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....